PrimeRFP SCOUT · Federal Contract Recompete Brief

W91YTZ23F0186Allergen extract vaccines — Greer Laboratories, Inc

PoP ended Sep 1, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

W40m Mrco East

Awarding office

Greer Laboratories, Inc

Recipient

Sep 1, 2023

PoP end

$261K

Obligated

$261K

Potential

325412

NAICS

6505

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Greer Laboratories, Inc — $90

Contract facts

Federal

Contract numberW91YTZ23F0186

Also listed asW91YTZ-23-F-0186

Also listed asW81K0423D0004-W91YTZ23F0186

AgencyW40m Mrco East

Awarding officeW40m Mrco East

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentGreer Laboratories, Inc

CAGE66447

UEILAEQA8NKSCE5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDVW81K0423D0004

Place of performanceFORT GEORGE G MEADE MD

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startSep 1, 2023

PoP end (current)Sep 1, 2023

Obligated$261K

Current value$261K

Potential value$261K

ALLERGEN EXTRACT VACCINES is a federal award for W40m Mrco East held by Greer Laboratories, Inc. Estimated value $261K ($261K obligated). Current period of performance ends Sep 1, 2023. Place of performance: FORT GEORGE G MEADE MD.

Recompete timing

Public

● Past PoP end (1106 days ago)

Current PoP ended Sep 1, 2023 (1106 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract W91YTZ23F0186?

W91YTZ23F0186 (Allergen extract vaccines) is a W40m Mrco East award with a potential value of $261K, currently held by Greer Laboratories, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W91YTZ-23-F-0186?

W91YTZ-23-F-0186 is the dashed form of PIID W91YTZ23F0186 (Allergen extract vaccines), held by Greer Laboratories, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W91YTZ23F0186?

W40m Mrco East awarded W91YTZ23F0186 to Greer Laboratories, Inc (potential $261K).

Who is the incumbent on W91YTZ23F0186?

Greer Laboratories, Inc is the incumbent. The current period of performance ends Sep 1, 2023.

When does Greer Laboratories, Inc’s W91YTZ23F0186 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 1, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on W91YTZ23F0186 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 27, 2023 · refreshed monthly